Lemtrada Stroke Lawsuit | Lawsuits for Lemtrada Stroke
Lawyers Helping Families Around the Nation Harmed by Lemtrada Stroke and Arterial Dissection
Lemtrada, a pharmaceutical drug approved to treat multiple sclerosis, has been linked to serious side effects that can result in permanent damage and death. Lemtrada causes arterial dissection (tears in the arterial lining of the head and neck) and stroke, caused by brain bleeding or lack of blood supply to the brain. Lemtrada stroke and artery tears are life-threatening events that kill brain cells and cause permanent brain damage. Lemtrada is already viewed as a risky treatment that should be used only after other drugs fail; today, some safety experts believe the Lemtrada stroke risk tips the scales, such that Lemtrada side effects outweigh the drug's potential benefits.
A product of Genzyme, a subsidiary of the French pharmaceutical giant Sanofi, Lemtrada was approved in 2014 to treat relapsing forms of multiple sclerosis (MS) because it was found to offer better treatment outcomes over comparable drugs. At the same time, FDA safety experts were cautious about the risks posed by Lemtrada, ordering a comprehensive risk evaluation and mitigation strategy (REMS) to ensure serious Lemtrada risks be managed. Initial Lemtrada problems included anaphylactic responses and cancer; the danger of stroke from Lemtrada was only announced as a result of post-market adverse event reports to the FDA. In other words, MS patients who have taken the drug since its release in 2014 were not warned about the Lemtrada stroke risk and were thus unknowingly exposed to a life-threatening complication. Annual sales of Lemtrada in the United States exceeded $275 million in 2017.
Now Sanofi Genzyme (the American division of the French pharmaceutical giant Sanofi) faces serious questions regarding Lemtrada side effects and early safety testing. Persons and the family members of persons who suffered from Lemtrada stroke or arterial dissection are filing Lemtrada lawsuits against Genzyme. Filing a Lemtrada stroke lawsuit is the only means individuals and families have to obtain the compensation they deserve for suffering, damage, medical expenses and loss related to Lemtrada stroke or arterial dissection. In addition, filing a Lemtrada lawsuit claim is the best method for individual consumers to hold Sanofi Genzyme executives accountable for the safety of this popular drug.
Attorneys for Lemtrada stroke lawsuits believe persons who have suffered from Lemtrada stroke may be eligible for significant compensation for the pain, suffering, medical expenses, and damage related to this dangerous drug. Persons and family members of persons having suffered from Lemtrada stroke are eligible for free, no-obligation case reviews with an attorney handling national Lemtrada lawsuits. Lawyers handling Lemtrada lawsuits work on contingency, meaning you will never pay legal fees unless we win compensation for you. Read full Lemtrada lawsuit information from attorneys handling stroke and arterial dissection claims from plaintiffs nationwide.
This page features answers to common questions regarding filing a Lemtrada stroke lawsuit. Compiled by leading national drug safety attorneys, the answers contained on this page apply to most general questions regarding Lemtrada lawsuit claims for stroke. Our attorneys handling Lemtrada lawsuit claims also offer free, no-obligation case consultation. Should you still have questions after reading the Lemtrada lawsuit FAQ or you would prefer to speak directly with a lawyer, please complete our contact form. Read full Lemtrada lawsuit questions and answers.
Our Lemtrada attorneys have a distinguished track record when it comes to winning major cases against multinational pharmaceutical conglomerates, earning the compensation our clients deserve. When a billion-dollar drug corporation makes business decisions that result in harm to consumers, our Lemtrada lawyer group sees it as their mission to pursue justice no matter how complex the case. Our attorneys handling Lemtrada claims for stroke help individuals and families recover the compensation they need and deserve, while holding companies accountable for consumer safety. Read full information from Lemtrada attorneys for filing a claim against Sanofi Genzyme.
In 2018, stroke and arterial dissection from Lemtrada were added to the list of severe Black Box warnings that accompany this multiple sclerosis drug. Arterial dissection, or tears in the linings of the head and neck arteries, can result in brain bleeding or lack of blood flow to the brain, causing Lemtrada stroke. These are life-threatening conditions that may result in permanent brain damage. Persons and family members of persons who have suffered from arterial dissection or stroke from Lemtrada may be eligible for compensation through filing a Lemtrada lawsuit. Read full Lemtrada stroke and arterial dissection information.
The FDA Lemtrada stroke warning was prompted by adverse event information indicating a significant risk for arterial dissection and stroke from Lemtrada. Published in November of 2018, the FDA Lemtrada stroke warning has left safety experts questioning whether Lemtrada's benefits still outweigh its risks. The FDA Lemtrada stroke warning fell short of prompting a Lemtrada recall but recommends the drug be used only as a last resort when other treatments have failed. Persons and family members of persons who developed stroke from Lemtrada with no prior warning of the risk may be eligible for compensation by filing a Lemtrada lawsuit against Sanofi. Read full
FDA Lemtrada warning information.
Disclaimer: The choice of an attorney is an important decision and should not be based solely upon advertisements. Past results afford no guarantee of future results. Every case is different and must be judged on its own merits. The accident, injury, personal injury, and/or other legal information offered herein by The Onder Law firm, is not formal legal advice, nor is it the formation of an attorney client relationship. In order for our firm to be considered your attorney there must be a signed agreement between the client and the firm.
The Onder Law Firm is a National Law Firm based in St. Louis, Missouri representing clients throughout the United States in national federal MDL products liability litigation.